Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned. Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel [...]

By |2020-04-18T10:55:36+00:00April 18th, 2020|Categories: News|0 Comments

Coronavirus mutation could threaten the race to develop vaccine

A coronavirus strain isolated in India carried a mutation that could upend vaccine development around the globe, according to researchers from Australia and Taiwan. The non-peer reviewed study said the change had occurred in part of the spike protein that allows the virus to bind with certain human cells. This structure targets cells containing [...]

By |2020-04-17T14:27:59+00:00April 17th, 2020|Categories: News|0 Comments

COVID-19: Anti-parasitic drug Ivermectin eliminates SARS-CoV-2 in cells in 48 hours

Ivermectin shows promise as potential COVID-19 therapy. Summary: An FDA-approved anti-parasitic drug called Ivermectin appears to inhibit and eliminate SARS-CoV-2 in lab-grown cell cultures within 48 hours. Ivermectin shows promise as potential COVID-19 therapy. However, researchers stress the need for further testing and clinical trials in humans to confirm the effectiveness of the drug [...]

By |2020-04-09T19:40:20+00:00April 9th, 2020|Categories: News|0 Comments

Severe Covid-19 illness in young possibly down to genes or ‘viral load’, scientists say

Coronavirus hits the old and those with other health problems hardest, but fit, youthful people are dying too, and experts are trying to understand why: It remains one of the biggest puzzles of the Covid-19 pandemic. The disease generally causes serious problems only in older people or those with underlying health problems. But occasionally it strikes [...]

By |2020-04-05T11:15:04+00:00April 5th, 2020|Categories: News|0 Comments

The race to find a coronavirus treatment has one major obstacle: Big Pharma

he past few weeks have revealed the worst and the best in human responses to the coronavirus crisis – from the supermarket hoarders clearing the shelves to the neighbourhood groups organising help for elderly and vulnerable people. When it comes to the pharmaceutical companies, how should we judge their response? They, after all, hold [...]

By |2020-04-02T10:29:11+00:00April 2nd, 2020|Categories: News|0 Comments

Oxford firm to screen 15,000 drugs in search for coronavirus cure

An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness as a treatment for Covid-19. Exscientia, a spinoff company from the University of Dundee that is now based in Oxford science park, said it had [...]

By |2020-04-01T12:35:44+00:00April 1st, 2020|Categories: News|0 Comments

New study sheds light on coronavirus infection mechanism

New research has shed light on a crucial biological mechanism that may have helped the coronavirus to infect humans and spread rapidly around the world. A detailed analysis of the virus’s structure shows that the club-like “spikes” that it uses to establish infections latch on to human cells about four times more strongly than [...]

By |2020-03-31T09:54:48+00:00March 31st, 2020|Categories: News|0 Comments

Comparing the coronavirus pandemic to past pathogenic threats: HIV, anthrax and Ebola

How does the COVID-19 pandemic compare to other infamous viral infections that have plagued us in modern times? It’s a question that’s been asked repeatedly in social media circles in recent weeks as people struggle to gain a better understanding of what we are facing. Recently, I received an answer that was terrifying. The [...]

By |2020-03-30T13:58:09+00:00March 30th, 2020|Categories: News|0 Comments

Nanoparticles could help us get closer to a treatment for COVID-19

There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to learn more about SARS-CoV-2, which is a strain from a family of viruses known as coronavirus for their crown-like shape. [...]

By |2020-03-19T12:52:05+00:00March 19th, 2020|Categories: News|0 Comments

Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.

Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy (CIDRAP), Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health, a professor in the Technological [...]

By |2020-03-16T15:35:24+00:00March 16th, 2020|Categories: News|0 Comments
Go to Top